Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Adverse drug reactions

Study finds gender differences in reporting adverse drug reactions

Researchers have shown that women are more likely to report adverse drug reactions than men, and suggested that this could lead to gender-based prescribing or monitoring in future.

Prescription bag

Source: ACORN 1 / Alamy Stock Photo

A study published in the British Journal of Pharmacology has shown that women are more likely to report an adverse drug reaction than men

Women are more likely to report adverse drug reactions (ADRs) to certain drugs than men, research published in the British Journal of Clinical Pharmacology has shown (2 April 2019)[1].

The study used data from the Netherlands on spontaneously reported ADRs, including 2,483 drug-ADR combinations that were reported at least ten times over a 13-year period.

Of a total 363 drug-ADR combinations that showed gender disparity, 322 (89%) were more commonly reported in women. For example, there were 32 drug-ADR combinations for thyroid hormones in women, 30 for antidepressants and 14 for tumour necrosis factor alpha. Certain types of ADR were also more common in women, such as nausea, alopecia, headache and dizziness, while men were more likely to experience ADRs such as aggression, sexual dysfunction and tendon rupture.

Previous research has shown that ADRs are more likely to be reported for women than men. The researchers said that their findings could lead to gender-based prescribing or monitoring in future.

“Further in-depth studies are needed for the specific drug-ADR combinations with possibly relevant gender differences to assess the individual contribution of potential factors,” they concluded.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2019.20206410

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.